Trending Now
Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of...
Amicus Therapeutics (NASDAQ:FOLD) has announced that the commencement of the rolling Biologics License Application submission to the US FDA for its experimental two-component therapy,...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announce That The RELIEF TNX-102 SL...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced that its Phase 3 RELIEF study of TNX-102 SL met its primary endpoint. TNX-102 SL...
MAKE IT MODERN
LATEST REVIEWS
Soligenix, Inc. Common Stock (NASDAQ:SNGX) Continues To Observe Positive Findings From...
Soligenix, Inc. Common Stock (NASDAQ:SNGX) recently announced that its synthetic hypericin or SGX301 continues to yield positive findings in a Phase 3 FLASH study...
MAKE IT MODERN
PERFORMANCE TRAINING
ADiTx Therapeutics Inc. (NASDAQ:ADTX) Completed Validation Of Studies of AditxtScore™ for COVID-19
The primary mission of ADiTx Therapeutics Inc. (NASDAQ:ADTX), is to enhance people’s immune systems through immune monitoring and reprogramming. However, it has been working...
Luxury Stocks in Focus as Spending Booms (SIG, SKDI, TPR)
Massive stimulus checks, extreme Fed easing, a strengthening inflationary outlook, rising employment, faster-than-expected vaccine rollout, and the movement out of the cold...
NeuroScience Therapeutics Ltd (NASDAQ: NRSN) Announces Biomarker Study Findings Evaluating CogniC in Alzheimer’s Disease
NeuroScience Therapeutics Ltd (NASDAQ: NRSN) has announced findings from a biomarker study performed to evaluate Cognic’s potential in Alzheimer’s disease (AD) treatment. CogniC is...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Receives Marketing Authorization For Firdapse To Cure Patients With LEMS:...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) received marketing authorization for Firdapse from Health Canada to treat patients with LEMS (Lambert-Eaton myasthenic syndrome) in Canada.
Marketing authorization under...
Heat Biologics Inc (NASDAQ:HTBX PTX-35) Administers PTX-35 To The First Patient At Its First...
Heat Biologics Inc (NASDAQ:HTBX PTX-35) has announced the commencement of its clinical trial for PTX-35, a COVID-19 vaccine candidate that the company developed.
The company...
MAKE IT MODERN
